{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["drug-drug interaction", "herbal bioinformatics", "in-silico toxicity prediction", "ligand-based virtual screening", "synergism", "triple-negative breast cancer"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36077464", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "02"}], "Language": ["eng"], "ELocationID": ["10056", "10.3390/ijms231710056"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "23", "Issue": "17", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "02"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "In-Silico Drug Toxicity and Interaction Prediction for Plant Complexes Based on Virtual Screening and Text Mining.", "Abstract": {"AbstractText": ["Potential drug toxicities and drug interactions of redundant compounds of plant complexes may cause unexpected clinical responses or even severe adverse events. On the other hand, super-additivity of drug interactions between natural products and synthetic drugs may be utilized to gain better performance in disease management. Although without enough datasets for prediction model training, based on the SwissSimilarity and PubChem platforms, for the first time, a feasible workflow of prediction of both toxicity and drug interaction of plant complexes was built in this study. The optimal similarity score threshold for toxicity prediction of this system is 0.6171, based on an analysis of 20 different herbal medicines. From the PubChem database, 31 different sections of toxicity information such as \"Acute Effects\", \"NIOSH Toxicity Data\", \"Interactions\", \"Hepatotoxicity\", \"Carcinogenicity\", \"Symptoms\", and \"Human Toxicity Values\" sections have been retrieved, with dozens of active compounds predicted to exert potential toxicities. In <i>Spatholobus suberectus</i> Dunn (SSD), there are 9 out of 24 active compounds predicted to play synergistic effects on cancer management with various drugs or factors. The synergism between SSD, luteolin and docetaxel in the management of triple-negative breast cancer was proved by the combination index assay, synergy score detection assay, and xenograft model."]}, "AuthorList": [{"Identifier": ["0000-0001-7422-5745"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen 518000, China."}], "LastName": "Zhang", "ForeName": "Feng", "Initials": "F"}, {"Identifier": ["0000-0002-3198-6066"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen 518000, China."}], "LastName": "Ganesan", "ForeName": "Kumar", "Initials": "K"}, {"Identifier": ["0000-0003-3020-6424"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen 518000, China."}], "LastName": "Li", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": ["0000-0001-6494-5271"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 10 Sassoon Road, Pokfulam, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Shenzhen Institute of Research and Innovation, The University of Hong Kong, Shenzhen 518000, China."}], "LastName": "Chen", "ForeName": "Jianping", "Initials": "J"}], "GrantList": [{"GrantID": "81573663", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "AB16450008", "Agency": "Guangxi Science and Technology Key Research and Development Program", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Data Mining"}, {"QualifierName": [], "DescriptorName": "Databases, Factual"}, {"QualifierName": [], "DescriptorName": "Drug-Related Side Effects and Adverse Reactions"}, {"QualifierName": [], "DescriptorName": "Fabaceae"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Triple Negative Breast Neoplasms"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Elghazaly H., Rugo H.S., Azim H.A., Swain S.M., Arun B., Aapro M., Perez E.A., Anderson B.O., Penault-Llorca F., Conte P., et al. Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer. Cancers. 2021;13:2262.", "ArticleIdList": ["PMC8125909", "34066769"]}, {"Citation": "Miles D., Gligorov J., Andre F., Cameron D., Schneeweiss A., Barrios C., Xu B., Wardley A., Kaen D., Andrade L., et al. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer. Ann. Oncol. 2021;32:994\u20131004. doi: 10.1016/j.annonc.2021.05.801.", "ArticleIdList": ["10.1016/j.annonc.2021.05.801", "34219000"]}, {"Citation": "Schmid P., Rugo H.S., Adams S., Schneeweiss A., Barrios C.H., Iwata H., Di\u00e9ras V., Henschel V., Molinero L., Chui S.Y., et al. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): Updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020;21:44\u201359. doi: 10.1016/S1470-2045(19)30689-8.", "ArticleIdList": ["10.1016/S1470-2045(19)30689-8", "31786121"]}, {"Citation": "Borghaei H., Gettinger S., Vokes E.E., Chow L.Q.M., Burgio M.A., de Castro Carpeno J., Pluzanski A., Arrieta O., Frontera O.A., Chiari R., et al. Five-Year Outcomes from the Randomized, Phase III Trials CheckMate 017 and 057, Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. J. Clin. Oncol. 2021;39:723\u2013733. doi: 10.1200/JCO.20.01605.", "ArticleIdList": ["10.1200/JCO.20.01605", "PMC8078445", "33449799"]}, {"Citation": "Zhao M.Y., Liu P., Sun C., Pei L.J., Huang Y.G. Propofol Augments Paclitaxel-Induced Cervical Cancer Cell Ferroptosis In Vitro. Front. Pharmacol. 2022;13:816432. doi: 10.3389/fphar.2022.816432.", "ArticleIdList": ["10.3389/fphar.2022.816432", "PMC9065257", "35517791"]}, {"Citation": "Li R.T., Zhu Y.D., Li W.Y., Hou Y.K., Zou Y.M., Zhao Y.H., Zou Q., Zhang W.H., Chen J.X. Synergistic photothermal-photodynamic-chemotherapy toward breast cancer based on a liposome-coated core-shell AuNS@NMOFs nanocomposite encapsulated with gambogic acid. J. Nanobiotechnol. 2022;20:212. doi: 10.1186/s12951-022-01427-4.", "ArticleIdList": ["10.1186/s12951-022-01427-4", "PMC9074336", "35524270"]}, {"Citation": "Date T., Kuche K., Chaudhari D., Ghadi R., Sahel D.K., Chitkara D., Jain S. Hitting Multiple Cellular Targets in Triple-Negative Breast Cancer Using Dual-Action Cisplatin(IV) Prodrugs for Safer Synergistic Chemotherapy. ACS Biomater. Sci. Eng. 2022;8:2349\u20132362. doi: 10.1021/acsbiomaterials.1c01582.", "ArticleIdList": ["10.1021/acsbiomaterials.1c01582", "35522530"]}, {"Citation": "Wang C., Gao H., Huang L., Wang Z., Ding X. Network Pharmacological Analysis and Experimental Study of the Antipharyngitis Mechanism of the Chaiqin Qingning Capsule. Biomed Res. Int. 2022;2022:5616942. doi: 10.1155/2022/5616942.", "ArticleIdList": ["10.1155/2022/5616942", "PMC9071881", "35528163"]}, {"Citation": "Li X., Ma J., Guo L., Dong C., Zhu G., Hong W., Chen C., Wang H., Wu X. Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics. Oxid. Med. Cell. Longev. 2022;2022:3145938. doi: 10.1155/2022/3145938.", "ArticleIdList": ["10.1155/2022/3145938", "PMC9073551", "35528524"]}, {"Citation": "Crowther N.R., Holbrook A.M., Kenwright R., Kenwright M. Drug interactions among commonly used medications. Chart simplifies data from critical literature review. Can. Fam. Physician. 1997;43", "ArticleIdList": ["PMC2255205", "9386884"]}, {"Citation": "Martin Y.C., Kofron J.L., Traphagen L.M. Do Structurally Similar Molecules Have Similar Biological Activity? J. Med. Chem. 2002;45:4350\u20134358. doi: 10.1021/jm020155c.", "ArticleIdList": ["10.1021/jm020155c", "12213076"]}, {"Citation": "Fan X., Zhao X., Jin Y., Shen X., Liu C. Network toxicology and its application to traditional Chinese medicine. Zhongguo Zhong Yao Za Zhi. 2011;36:2920\u20132922.", "ArticleIdList": ["22308674"]}, {"Citation": "Ridings J.E., Barratt M.D., Cary R., Earnshaw C.G., Eggington C.E., Ellis M.K., Judson P.N., Langowski J.J., Marchant C.A., Payne M.P., et al. Computer prediction of possible toxic action from chemical structure: An update on the DEREK system. Toxicology. 1996;106:267\u2013279. doi: 10.1016/0300-483X(95)03190-Q.", "ArticleIdList": ["10.1016/0300-483X(95)03190-Q", "8571398"]}, {"Citation": "Jeliazkova N., Jeliazkov V. AMBIT RESTful web services: An implementation of the OpenTox application programming interface. J. Cheminform. 2011;3:18. doi: 10.1186/1758-2946-3-18.", "ArticleIdList": ["10.1186/1758-2946-3-18", "PMC3120779", "21575202"]}, {"Citation": "Grulke C.M., Williams A.J., Thillanadarajah I., Richard A.M. EPA\u2019s DSSTox database: History of development of a curated chemistry resource supporting computational toxicology research. Comput. Toxicol. 2019;12:100096. doi: 10.1016/j.comtox.2019.100096.", "ArticleIdList": ["10.1016/j.comtox.2019.100096", "PMC7787967", "33426407"]}, {"Citation": "Langton K., Patlewicz G.Y., Long A., Marchant C.A., Basketter D.A. Structure-activity relationships for skin sensitization: Recent improvements to Derek for Windows. Contact Dermat. 2006;55:342\u2013347. doi: 10.1111/j.1600-0536.2006.00969.x.", "ArticleIdList": ["10.1111/j.1600-0536.2006.00969.x", "17101009"]}, {"Citation": "Greene N., Judson P.N., Langowski J.J., Marchant C.A. Knowledge-based expert systems for toxicity and metabolism prediction: DEREK, StAR and METEOR. SAR QSAR Environ. Res. 1999;10:299\u2013314. doi: 10.1080/10629369908039182.", "ArticleIdList": ["10.1080/10629369908039182", "10491855"]}, {"Citation": "Benfenati E., Gini G. Computational predictive programs (expert systems) in toxicology. Toxicology. 1997;119:213\u2013225. doi: 10.1016/S0300-483X(97)03631-7.", "ArticleIdList": ["10.1016/S0300-483X(97)03631-7", "9152017"]}, {"Citation": "Poroikov V., Filimonov D., Lagunin A., Gloriozova T., Zakharov A. PASS: Identification of probable targets and mechanisms of toxicity. SAR QSAR Environ. Res. 2007;18:101\u2013110. doi: 10.1080/10629360601054032.", "ArticleIdList": ["10.1080/10629360601054032", "17365962"]}, {"Citation": "Cunningham A.R., Carrasquer C.A., Mattison D.R. A categorical structure-activity relationship analysis of the developmental toxicity of antithyroid drugs. Int. J. Pediatr. Endocrinol. 2009;2009:936154. doi: 10.1186/1687-9856-2009-936154.", "ArticleIdList": ["10.1186/1687-9856-2009-936154", "PMC2810459", "20111734"]}, {"Citation": "Gallegos-Saliner A., Poater A., Jeliazkova N., Patlewicz G., Worth A.P. Toxmatch\u2014A chemical classification and activity prediction tool based on similarity measures. Regul. Toxicol. Pharmacol. 2008;52:77\u201384. doi: 10.1016/j.yrtph.2008.05.012.", "ArticleIdList": ["10.1016/j.yrtph.2008.05.012", "18617309"]}, {"Citation": "Pedretti A., Mazzolari A., Gervasoni S., Fumagalli L., Vistoli G. The VEGA suite of programs: An versatile platform for cheminformatics and drug design projects. Bioinformatics. 2021;37:1174\u20131175. doi: 10.1093/bioinformatics/btaa774.", "ArticleIdList": ["10.1093/bioinformatics/btaa774", "33289523"]}, {"Citation": "Tomasulo P. ChemIDplus-super source for chemical and drug information. Med. Ref. Serv. Q. 2002;21:53\u201359. doi: 10.1300/J115v21n01_04.", "ArticleIdList": ["10.1300/J115v21n01_04", "11989279"]}, {"Citation": "Roy K., Kar S. In Silico Models for Ecotoxicity of Pharmaceuticals. Methods Mol. Biol. 2016;1425:237\u2013304.", "ArticleIdList": ["PMC7120582", "27311470"]}, {"Citation": "Kar S., Leszczynski J. Exploration of Computational Approaches to Predict the Toxicity of Chemical Mixtures. Toxics. 2019;7:15. doi: 10.3390/toxics7010015.", "ArticleIdList": ["10.3390/toxics7010015", "PMC6468900", "30893892"]}, {"Citation": "Prival M.J. Evaluation of the TOPKAT system for predicting the carcinogenicity of chemicals. Environ. Mol. Mutagen. 2001;37:55\u201369. doi: 10.1002/1098-2280(2001)37:1<55::AID-EM1006>3.0.CO;2-5.", "ArticleIdList": ["10.1002/1098-2280(2001)37:1<55::AID-EM1006>3.0.CO;2-5", "11170242"]}, {"Citation": "Mombelli E. An evaluation of the predictive ability of the QSAR software packages, DEREK, HAZARDEXPERT and TOPKAT, to describe chemically-induced skin irritation. Altern. Lab. Anim. 2008;36:15\u201324. doi: 10.1177/026119290803600104.", "ArticleIdList": ["10.1177/026119290803600104", "18333711"]}, {"Citation": "Lewi D.F., Bird M.G., Jacobs M.N. Human carcinogens: An evaluation study via the COMPACT and HazardExpert procedures. Hum. Exp. Toxicol. 2002;21:115\u2013122.", "ArticleIdList": ["12102536"]}, {"Citation": "Morita T., Shigeta Y., Kawamura T., Fujita Y., Honda H., Honma M. In silico prediction of chromosome damage: Comparison of three (Q)SAR models. Mutagenesis. 2019;34:91\u2013100. doi: 10.1093/mutage/gey017.", "ArticleIdList": ["10.1093/mutage/gey017", "30085209"]}, {"Citation": "Kim S., Chen J., Cheng T., Gindulyte A., He J., He S., Li Q., Shoemaker B.A., Thiessen P.A., Yu B., et al. PubChem in 2021, new data content and improved web interfaces. Nucleic Acids Res. 2021;49:D1388\u2013D1395. doi: 10.1093/nar/gkaa971.", "ArticleIdList": ["10.1093/nar/gkaa971", "PMC7778930", "33151290"]}, {"Citation": "O\u2019Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R. Open Babel: An open chemical toolbox. J. Cheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33.", "ArticleIdList": ["10.1186/1758-2946-3-33", "PMC3198950", "21982300"]}, {"Citation": "Rogers D., Hahn M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 2010;50:742\u2013754. doi: 10.1021/ci100050t.", "ArticleIdList": ["10.1021/ci100050t", "20426451"]}, {"Citation": "Probst D., Reymond J.L. A probabilistic molecular fingerprint for big data settings. J. Cheminform. 2018;10:66. doi: 10.1186/s13321-018-0321-8.", "ArticleIdList": ["10.1186/s13321-018-0321-8", "PMC6755601", "30564943"]}, {"Citation": "Brown B.P., Vu O., Geanes A.R., Kothiwale S., Butkiewicz M., Lowe E.W., Jr., Mueller R., Pape R., Mendenhall J., Meiler J. Introduction to the BioChemical Library (BCL): An Application-Based Open-Source Toolkit for Integrated Cheminformatics and Machine Learning in Computer-Aided Drug Discovery. Front. Pharmacol. 2022;13:833099. doi: 10.3389/fphar.2022.833099.", "ArticleIdList": ["10.3389/fphar.2022.833099", "PMC8899505", "35264967"]}, {"Citation": "Gobbi A., Poppinger D. Genetic optimization of combinatorial libraries. Biotechnol. Bioeng. 1998;61:47\u201354. doi: 10.1002/(SICI)1097-0290(199824)61:1<47::AID-BIT9>3.0.CO;2-Z.", "ArticleIdList": ["10.1002/(SICI)1097-0290(199824)61:1<47::AID-BIT9>3.0.CO;2-Z", "10099495"]}, {"Citation": "Stiefl N., Watson I.A., Baumann K., Zaliani A. ErG: 2D pharmacophore descriptions for scaffold hopping. J. Chem. Inf. Model. 2006;46:208\u2013220. doi: 10.1021/ci050457y.", "ArticleIdList": ["10.1021/ci050457y", "16426057"]}, {"Citation": "Armstrong M.S., Finn P.W., Morris G.M., Richards W.G. Improving the accuracy of ultrafast ligand-based screening: Incorporating lipophilicity into ElectroShape as an extra dimension. J. Comput.-Aided Mol. Des. 2011;25:785\u2013790. doi: 10.1007/s10822-011-9463-8.", "ArticleIdList": ["10.1007/s10822-011-9463-8", "21822723"]}, {"Citation": "Bragina M.E., Daina A., Perez M.A.S., Michielin O., Zoete V. The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience. Int. J. Mol. Sci. 2022;23:811. doi: 10.3390/ijms23020811.", "ArticleIdList": ["10.3390/ijms23020811", "PMC8776004", "35054998"]}, {"Citation": "Axen S.D., Huang X.P., Caceres E.L., Gendelev L., Roth B.L., Keiser M.J. A Simple Representation of Three-Dimensional Molecular Structure. J. Med. Chem. 2017;60:7393\u20137409. doi: 10.1021/acs.jmedchem.7b00696.", "ArticleIdList": ["10.1021/acs.jmedchem.7b00696", "PMC6075869", "28731335"]}, {"Citation": "Gfeller D., Michielin O., Zoete V. Shaping the interaction landscape of bioactive molecules. Bioinformatics. 2013;29:3073\u20133079. doi: 10.1093/bioinformatics/btt540.", "ArticleIdList": ["10.1093/bioinformatics/btt540", "24048355"]}, {"Citation": "Choi Y.H., Suh J.H., Lee J.H., Cho I.H., Lee M.G. Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats. J. Pharm. Pharmacol. 2010;62:1084\u20131088. doi: 10.1111/j.2042-7158.2010.01129.x.", "ArticleIdList": ["10.1111/j.2042-7158.2010.01129.x", "20663044"]}, {"Citation": "Van Waterschoot R.A., Lagas J.S., Wagenaar E., van der Kruijssen C.M., van Herwaarden A.E., Song J.Y., Rooswinkel R.W., van Tellingen O., Rosing H., Beijnen J.H., et al. Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity. Cancer Res. 2009;69:8996\u20139002. doi: 10.1158/0008-5472.CAN-09-2915.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-2915", "19920203"]}, {"Citation": "Van Zuylen L., Verweij J., Nooter K., Brouwer E., Stoter G., Sparreboom A. Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans. Clin. Cancer Res. 2000;6:2598\u20132603.", "ArticleIdList": ["10914699"]}, {"Citation": "National Comprehensive Cancer Network  NCCN Guidelines Version 4.2022 Breast Cancer.  [(accessed on 29 June 2022)].  Available online:  https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf."}, {"Citation": "Mayr F., Moller G., Garscha U., Fischer J., Rodriguez Castano P., Inderbinen S.G., Temml V., Waltenberger B., Schwaiger S., Hartmann R.W., et al. Finding New Molecular Targets of Familiar Natural Products Using In Silico Target Prediction. Int. J. Mol. Sci. 2020;21:7102. doi: 10.3390/ijms21197102.", "ArticleIdList": ["10.3390/ijms21197102", "PMC7582679", "32993084"]}, {"Citation": "Bender A., Glen R.C. Molecular similarity: A key technique in molecular informatics. Org. Biomol. Chem. 2004;2:3204\u20133218. doi: 10.1039/b409813g.", "ArticleIdList": ["10.1039/b409813g", "15534697"]}, {"Citation": "Yadav J., Paragas E., Korzekwa K., Nagar S. Time-dependent enzyme inactivation: Numerical analyses of in vitro data and prediction of drug-drug interactions. Pharmacol. Ther. 2020;206:107449. doi: 10.1016/j.pharmthera.2019.107449.", "ArticleIdList": ["10.1016/j.pharmthera.2019.107449", "PMC6995442", "31836452"]}, {"Citation": "Nozaki Y., Izumi S. Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters. Drug Metab. Pharmacokinet. 2020;35:56\u201370. doi: 10.1016/j.dmpk.2019.11.004.", "ArticleIdList": ["10.1016/j.dmpk.2019.11.004", "31901416"]}, {"Citation": "Ryu J.Y., Kim H.U., Lee S.Y. Deep learning improves prediction of drug-drug and drug-food interactions. Proc. Natl. Acad. Sci. USA. 2018;115:E4304\u2013E4311. doi: 10.1073/pnas.1803294115.", "ArticleIdList": ["10.1073/pnas.1803294115", "PMC5939113", "29666228"]}, {"Citation": "Nickel J., Gohlke B.O., Erehman J., Banerjee P., Rong W.W., Goede A., Dunkel M., Preissner R. SuperPred: Update on drug classification and target prediction. Nucleic Acids Res. 2014;42:W26\u2013W31. doi: 10.1093/nar/gku477.", "ArticleIdList": ["10.1093/nar/gku477", "PMC4086135", "24878925"]}, {"Citation": "Keiser M.J., Setola V., Irwin J.J., Laggner C., Abbas A.I., Hufeisen S.J., Jensen N.H., Kuijer M.B., Matos R.C., Tran T.B., et al. Predicting new molecular targets for known drugs. Nature. 2009;462:175\u2013181. doi: 10.1038/nature08506.", "ArticleIdList": ["10.1038/nature08506", "PMC2784146", "19881490"]}, {"Citation": "D\u2019Abreo N., Adams S. Immune-checkpoint inhibition for metastatic triple-negative breast cancer: Safety first? Nat. Rev. Clin. Oncol. 2019;16:399\u2013400. doi: 10.1038/s41571-019-0216-2.", "ArticleIdList": ["10.1038/s41571-019-0216-2", "31053774"]}, {"Citation": "Sternschuss M., Yerushalmi R., Saleh R.R., Amir E., Goldvaser H. Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: A systematic review and meta-analysis. J. Cancer Res. Clin. Oncol. 2021;147:3369\u20133379. doi: 10.1007/s00432-021-03591-w.", "ArticleIdList": ["10.1007/s00432-021-03591-w", "33745080"]}, {"Citation": "Ru J., Li P., Wang J., Zhou W., Li B., Huang C., Li P., Guo Z., Tao W., Yang Y., et al. TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J. Cheminform. 2014;6:13. doi: 10.1186/1758-2946-6-13.", "ArticleIdList": ["10.1186/1758-2946-6-13", "PMC4001360", "24735618"]}, {"Citation": "Gaulton A., Hersey A., Nowotka M., Bento A.P., Chambers J., Mendez D., Mutowo P., Atkinson F., Bellis L.J., Cibrian-Uhalte E., et al. The ChEMBL database in 2017. Nucleic Acids Res. 2017;45:D945\u2013D954. doi: 10.1093/nar/gkw1074.", "ArticleIdList": ["10.1093/nar/gkw1074", "PMC5210557", "27899562"]}, {"Citation": "Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u20132504. doi: 10.1101/gr.1239303.", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Zhang F., Liu Q., Ganesan K., Kewu Z., Shen J., Gang F., Luo X., Chen J. The Antitriple Negative Breast cancer Efficacy of Spatholobus suberectus Dunn on ROS-Induced Noncanonical Inflammasome Pyroptotic Pathway. Oxid. Med. Cell. Longev. 2021;2021:5187569. doi: 10.1155/2021/5187569.", "ArticleIdList": ["10.1155/2021/5187569", "PMC8514942", "34659633"]}, {"Citation": "Chou T.-C. Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies. Pharmacol. Rev. 2006;58:621\u2013681. doi: 10.1124/pr.58.3.10.", "ArticleIdList": ["10.1124/pr.58.3.10", "16968952"]}, {"Citation": "Zheng S., Wang W., Aldahdooh J., Malyutina A., Shadbahr T., Tanoli Z., Pessia A., Tang J. SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets. Genom. Proteom. Bioinform. 2022 doi: 10.1016/j.gpb.2022.01.004. in press .", "ArticleIdList": ["10.1016/j.gpb.2022.01.004", "PMC9801064", "35085776"]}, {"Citation": "Yadav B., Wennerberg K., Aittokallio T., Tang J. Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model. Comput. Struct. Biotechnol. J. 2015;13:504\u2013513. doi: 10.1016/j.csbj.2015.09.001.", "ArticleIdList": ["10.1016/j.csbj.2015.09.001", "PMC4759128", "26949479"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "19"}, {"Year": "2022", "Month": "8", "Day": "30"}, {"Year": "2022", "Month": "9", "Day": "1"}, {"Year": "2022", "Month": "9", "Day": "9", "Hour": "1", "Minute": "9"}, {"Year": "2022", "Month": "9", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["36077464", "PMC9456415", "10.3390/ijms231710056", "ijms231710056"]}}], "PubmedBookArticle": []}